Desq Long
Sign in

Company

4D Molecular Therapeutics, Inc.

FDMT · CIK 0001650648

SEC FORM 4
$6,768.90

4D Molecular Therapeutics, Inc. (FDMT)

Acquisition (code M) of 1,635 shares at $4.14 per share.

Reporting Person Bizily Scott · Officer Title Chief Legal Officer · Transaction Code M

Traded Oct 16, 2026 · Disclosed Oct 20, 2026

Source: SEC Form 4 · 0001193125-26-426810 · filed 2026-10-20 · View filing →

SEC FORM 4
$20,993.40

4D Molecular Therapeutics, Inc. (FDMT)

Sale of 1,635 shares at $12.84 per share.

Reporting Person Bizily Scott · Officer Title Chief Legal Officer · Transaction Code S

Traded Oct 16, 2026 · Disclosed Oct 20, 2026

Source: SEC Form 4 · 0001193125-26-426810 · filed 2026-10-20 · View filing →

SEC FORM 4
$750,235.21

4D Molecular Therapeutics, Inc. (FDMT)

Sale of 58,061 shares at $12.9215 per share.

Reporting Person Kirn David · Officer Title See Remarks · Transaction Code S

Traded Oct 5, 2026 · Disclosed Oct 7, 2026

Source: SEC Form 4 · 0001193125-26-417068 · filed 2026-10-07 · View filing →

SEC FORM 4
$3,702.03

4D Molecular Therapeutics, Inc. (FDMT)

Sale of 272 shares at $13.6104 per share.

Reporting Person Kirn David · Officer Title See Remarks · Transaction Code S

Traded Oct 5, 2026 · Disclosed Oct 7, 2026

Source: SEC Form 4 · 0001193125-26-417068 · filed 2026-10-07 · View filing →

SEC FORM 4
$6,768.90

4D Molecular Therapeutics, Inc. (FDMT)

Acquisition (code M) of 1,635 shares at $4.14 per share.

Reporting Person Bizily Scott · Officer Title Chief Legal Officer · Transaction Code M

Traded Sep 16, 2026 · Disclosed Sep 22, 2026FILED +6 DAYS

Source: SEC Form 4 · 0001193125-26-398204 · filed 2026-09-22 · View filing →

SEC FORM 4
$22,317.75

4D Molecular Therapeutics, Inc. (FDMT)

Sale of 1,635 shares at $13.65 per share.

Reporting Person Bizily Scott · Officer Title Chief Legal Officer · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 22, 2026FILED +6 DAYS

Source: SEC Form 4 · 0001193125-26-398204 · filed 2026-09-22 · View filing →

SEC FORM 4
$811,003.70

4D Molecular Therapeutics, Inc. (FDMT)

Sale of 58,333 shares at $13.903 per share.

Reporting Person Kirn David · Officer Title See Remarks · Transaction Code S

Traded Sep 14, 2026 · Disclosed Sep 16, 2026

Source: SEC Form 4 · 0001193125-26-393243 · filed 2026-09-16 · View filing →

SEC FORM 4
$3,790.16

4D Molecular Therapeutics, Inc. (FDMT)

Acquisition (code M) of 584 shares at $6.49 per share.

Reporting Person Bizily Scott · Officer Title Chief Legal Officer · Transaction Code M

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001193125-26-382245 · filed 2026-09-03 · View filing →

SEC FORM 4
$8,176.00

4D Molecular Therapeutics, Inc. (FDMT)

Sale of 584 shares at $14 per share.

Reporting Person Bizily Scott · Officer Title Chief Legal Officer · Transaction Code S

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001193125-26-382245 · filed 2026-09-03 · View filing →

SEC FORM 4
$207,000.00

4D Molecular Therapeutics, Inc. (FDMT)

Acquisition (code M) of 50,000 shares at $4.14 per share.

Reporting Person Kirn David · Officer Title See Remarks · Transaction Code M

Traded Aug 19, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0001193125-26-361096 · filed 2026-08-21 · View filing →

SEC FORM 4
$662,621.93

4D Molecular Therapeutics, Inc. (FDMT)

Sale of 43,149 shares at $15.3566 per share.

Reporting Person Kirn David · Officer Title See Remarks · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0001193125-26-361096 · filed 2026-08-21 · View filing →

SEC FORM 4
$425,651.34

4D Molecular Therapeutics, Inc. (FDMT)

Sale of 25,927 shares at $16.4173 per share.

Reporting Person Kirn David · Officer Title See Remarks · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0001193125-26-361096 · filed 2026-08-21 · View filing →

SEC FORM 4
$6,768.90

4D Molecular Therapeutics, Inc. (FDMT)

Acquisition (code M) of 1,635 shares at $4.14 per share.

Reporting Person Bizily Scott · Officer Title Chief Legal Officer · Transaction Code M

Traded Aug 17, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0001193125-26-354313 · filed 2026-08-17 · View filing →

SEC FORM 4
$19,947.00

4D Molecular Therapeutics, Inc. (FDMT)

Sale of 1,635 shares at $12.2 per share.

Reporting Person Bizily Scott · Officer Title Chief Legal Officer · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0001193125-26-354313 · filed 2026-08-17 · View filing →

SEC FORM 4
$6,768.90

4D Molecular Therapeutics, Inc. (FDMT)

Acquisition (code M) of 1,635 shares at $4.14 per share.

Reporting Person Bizily Scott · Officer Title Chief Legal Officer · Transaction Code M

Traded Aug 13, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0001193125-26-354313 · filed 2026-08-17 · View filing →

SEC FORM 4
$19,620.00

4D Molecular Therapeutics, Inc. (FDMT)

Sale of 1,635 shares at $12 per share.

Reporting Person Bizily Scott · Officer Title Chief Legal Officer · Transaction Code S

Traded Aug 13, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0001193125-26-354313 · filed 2026-08-17 · View filing →